Insider filing · HALO

Jeffrey William Henderson sold $500K of Halozyme Therapeutics (HALO)

Executed Jan 6 2025, disclosed Jan 7 2025, 1 day later.

Returns are measured on stock purchases only.

JH Jeffrey William Henderson Director profile →

Jeffrey William Henderson (Director) filed 5 Form 4 reports in the past 24 months (1 purchase, 4 sales), most often in Halozyme Therapeutics, Inc. (HALO). Across 1 priced purchase filing, the average 21-session return was -1.7% from execution and -1.7% from disclosure (delay-adjusted; derived). The largest single filing was $500K of HALO (10,000 sh × $50.01, as filed), executed Jan 6 2025.

HALO Halozyme Therapeutics, Inc. HALO · Healthcare · 39 filings in 24 months ticker →

Healthcare · Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in th…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→